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Background: Spatial data on cases are available either in point form (e.g. longitude/latitude), or aggregated by an
administrative region (e.g. zip code or census tract). Statistical methods for spatial data may accommodate either
form of data, however the spatial aggregation can affect their performance. Previous work has studied the effect of
spatial aggregation on cluster detection methods. Here we consider geographic health data at different levels of
spatial resolution, to study the effect of spatial aggregation on disease mapping performance in locating
subregions of increased disease risk.
Methods: We implemented a non-parametric disease distance-based mapping (DBM) method to produce a
smooth map from spatially aggregated childhood leukaemia data. We then simulated spatial data under controlled
conditions to study the effect of spatial aggregation on its performance. We used an evaluation method based on
ROC curves to compare performance of DBM across different geographic scales.
Results: Application of DBM to the leukaemia data illustrates the method as a useful visualization tool. Spatial
aggregation produced expected degradation of disease mapping performance. Characteristics of this degradation,
however, varied depending on the interaction between the geographic extent of the higher risk area and the level
of aggregation. For example, higher risk areas dispersed across several units did not suffer as greatly from
aggregation. The choice of centroids also had an impact on the resulting mapping.
Conclusions: DBM can be implemented for continuous and discrete spatial data, but the resulting mapping can
lose accuracy in the second setting. Investigation of the simulations suggests a complex relationship between
performance loss, geographic extent of spatial disturbances and centroid locations. Aggregation of spatial data
destroys information and thus impedes efforts to monitor these data for spatial disturbances. The effect of spatial
aggregation on cluster detection, disease mapping, and other useful methods in spatial epidemiology is complex
and deserves further study.
Keywords: Disease risk mapping, Distance-based mapping, Spatial data, Aggregation effect, Scale effect, MAUP,
Simulations, Spatial epidemiologyBackground
As John Snow demonstrated so effectively with the
cluster of cholera cases around the Broad Street pump,
geographic location of disease cases can be a crucial
first step to identify and eventually prevent the source
of disease outbreaks [1,2]. We continue this tradition
in the modern practice of public health, where under-
standing the epidemiology of disease informs the* Correspondence: cjeffery@liv.ac.uk
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Spatial information on cases can reveal the spread of
disease across a region, or it can be incorporated in
statistical analyses [3-5], but these data are complex
with many characteristics that might influence analysis
[6]. In particular the level of precision of the spatial data
is an aspect with immediate analytic considerations, and
several studies have shown that accurately identifying the
geographic spread of a spatial disturbance depends upon
the level of precision of the spatial data [7-9].
When case locations are reported, they are available in
either point or aggregated form. For the former, theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ring to Cartesian coordinates or to longitude and latitude.
We refer to them as continuous spatial data. Alternatively,
the location of a case can be given in aggregated form as a
subset of the study region called the aggregation unit, typic-
ally an administrative level such as ZIP code or census tract.
The subregion is often available with a centroid represented
by a pair of coordinates. The centroid describes the ‘center’
of the unit, and is typically chosen to be the location of the
administrative or geographic center of the unit. This
coarser spatial data on cases can result from the collection
process or might have been intentionally aggregated due to
privacy. We call this form of data discrete spatial data.
Measuring the effect of spatial aggregation is the study of
determining how the performance of a statistical method is
affected when the spatial data are available in a discrete
fashion rather than continuous (e.g. ZIP code vs longitude
and latitude), or in one discrete level versus another (e.g.
ZIP code vs census tract) [10]. This effect is also termed ef-
fect of scale or effect of discretisation, and is a particular as-
pect of the Modifiable Areal Unit Problem [10].
Spatial methods are usually classified into addressing
one of three problems: cluster detection, clustering,
and spatial variation in risk [11,12]. Several authors
have studied the effect of spatial aggregation on some
of the spatial methods used in disease surveillance (see
[7] and references therein). Some studies have shown
that cluster detection methods [12] applied to data ag-
gregated at a coarser scale will result in a loss of sta-
tistical power. Most of these studies are limited in the
number of spatial alternatives and the number of
discrete aggregation levels considered. When the geo-
graphic or population size of the cluster varies, and
when many levels of aggregation are considered, the
impact on power can involve a complex relationship
between the geographical extent of the cluster and that
of the aggregation unit [7,9,13]. As an alternative to
studying the relationship between an individual's loca-
tion and the acquisition of disease, exploratory disease
mapping methods estimate a change in the spatial dis-
tribution of cases from a reference distribution, which
represents a residual spatial risk surface after all
known risk factors have been accounted for [12,14].
With continuous spatial data, one can estimate the log
ratio of two inhomogeneous Poisson process in-
tensities [15,16], or a combined measure comparing
the two distributions on several one-dimensional scales
[17,18]. Both approaches define their estimator as a func-
tion mapping any point in the study region to a real value.
With discrete spatial data, one usually determines a single
value for each aggregated unit (e.g. rate, proportion), and
statistical smoothing techniques are available to account
for varying population sizes, influence of neighboring
units, and other variables [12,14,19-23].Regardless of the input data, the output of disease
mapping is a set of values associated with a regular grid
of points atop the study region. With discrete data, we
typically assign a single estimate to all grid points in the
same unit, or to the centroid of the unit only, using kri-
ging or interpolation to define values at the remaining
grid points [24]. The caveat is that this second approach
may result in non-positive values [14]. Finally we use a
color scale to visualize how the estimate varies across
the study region.
In this paper we consider a non-parametric distance-
based mapping (DBM) approach [17,18], and measure
the effect of spatial aggregation on its performance. In
the next section, we describe our methods in the context
of continuous and discrete data. We then illustrate the
utility of our approach with an application to childhood
leukaemia data from upstate New York [25,26], and
simulate data to compare estimation of a dichotomized
risk in the unit disk under several levels of aggregation
versus continuous data. We conclude with some obser-
vations and discussion on the advantages and limitations
of our proposed approach.
Methods
We consider spatial methods for the display or analysis
of a quantitative variable across a study region. Typical
examples might be a climate variable (e.g. temperature,
rainfall); an environmental exposure (carbon monoxide
concentration, PM10 pollution); or an epidemiologic
measure (e.g. prevalence or cumulative incidence of a
disease). The spatial data available might consist of a
sampled measurement of the variable at several fixed lo-
cations, or captured locations of a particular event. In ei-
ther case, we aim to estimate the variable of interest at
any location in the study region, at which point we say
such an estimate maps the variable across the study re-
gion. Here we focus on approaches that map a risk of
disease, for which the available data consist either of lo-
cations or aggregated counts of diagnosed cases.
Several measures from classical epidemiology are com-
monly used to represent risk: incidence rate, rate ratio
(RR), or odds ratio (OR) are well-known examples. Inci-
dence is defined with respect to an underlying popula-
tion and time period, while RR or OR compare rates or
odds respectively between two distinct exposure groups.
When defining a risk function on a study region, we
frame the function and its estimation as a comparison of
two components, observed and expected. For example,
observed locations of cancer cases can be compared with a
representative sample from the population-at-risk [25,27].
Likewise, ongoing spatial monitoring of syndromic sur-
veillance data might compare locations of respiratory ill-
ness during a particular week to those reported previous
weeks [13]. Heterogeneity of spatial distribution of cases
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throughout the region, and this is incorporated appro-
priately into the expected component.Notation and definitions
Consider a study region S, a bounded subset of a two-
dimensional Euclidean space, which simultaneously rep-
resents the spatial support for our data and the domain
of the associated mapping function, and a finite set of
grid points S’ which are chosen by superimposing a lat-
tice over the study region:
Definition: Let S’ = {y1,…,yr} in S be a finite collection
of points in R2. We call any real-valued function M:
S’→ R a (disease risk) mapping function, and we call the
range of M, i.e. the set of function values {M(y1),…,M
(yr)}, the set of (disease) scores.
In practice, we find it convenient to represent S by its
finite subset S’, and will simply write S for the grid point
subset wherever this is clear. The definition above ex-
tends in the natural way to regions S embedded within
higher dimensional spaces, but we focus on applications
which model spatial locations in the Euclidean plane.
Given a set of observations, an estimator of M is a
real-valued function M^ defined on S. In our context, we
define the sample space and the mapping function more
precisely. When spatial data are continuous, we assume
that each spatial location of a case is a single point in S.
Conversely when spatial data are discrete, we suppose
that S can be divided into m non-intersecting subregions
{S1,…,Sm} with each subregion labeled by a centroid
point zi in Si. The centroid refers to the geographic cen-
ter of the unit. When the spatial data of each case is
discrete, that case location is one of these subregions,
along with its centroid, and we define the sample space
as the collection of centroids {z1,…,zm}.
Finally we consider the bivariate random vector X
drawn from an underlying probability distribution repre-
senting the location of cases in the continuous setting and
let f: R2→ R be the corresponding probability distribution
function (PDF). We frame a disease risk mapping function
as a comparison between f and a reference function f0:
R2→ R defined throughout the region S, where f and f0
represent respectively the ‘observed’ spatial distribution of
cases and the ‘expected’ distribution based on population
and other factors. In the discrete setting, we define similar
PDF f(m):R2→ R and a disease risk mapping function is
framed as a comparison of the observed f(m) to an ex-
pected reference function f mð Þ0 : R
2→ R throughout the re-
gion. We link the two settings by a function mapping
locations to the corresponding subregion centroids. Thus
we consider both discrete and spatial mapping within the
same probabilistic framework which allows us to build
upon previous work [17,18].Disease mapping for continuous and discrete data
We now suppose our data consist of disease case loca-
tions diagnosed during a specified time period. For each
case we observe a location in S. The general motivation
behind the mapping approach proposed by Jeffery et al.
[17,18] is to avert the curse-of-dimensionality (CoD) by
comparing the observed and expected spatial distribu-
tions in one dimension only. The CoD occurs if the per-
formance of a statistical method is heavily diminished
when applied to higher dimensional data, unless the
sample size is increased beyond practical values. The
phenomenon is explained by the fact that, when the di-
mension of the data increases, the volume of the sample
space grows exponentially in comparison to the sample
size [28,29]. While the CoD may be manageable in two
dimensions, this approach generalizes naturally and
without great penalty to higher dimensions, where the
effect of the curse is much more severe. Any potential
loss of information from the projection is recovered by
considering multiple projections from different angles
and combining these comparisons. Inspired by tomo-
graphic imaging, the two-dimensional space is studied as
a fixed number of one-dimensional slices.
Briefly summarizing the methodology, we place a fixed
number N of fixed points ci along a circle circumscribed
to S. Each point ci defines a projection, where the one-
dimensional counterpart of X is defined as the Euclidean
distance d = ||ci – X||, with associated cumulative dis-
tribution function (CDF) Fi(d) and F0(d). The one-
dimensional comparison of Fi and F0 is constructed as a
function γi: R→ R estimated via numerical integration.
The comparator γi is usually chosen as the difference be-
tween the two integrals but other functions, such as a
weighted difference or a ratio, have been proposed. The
widths of the projections are modified adaptively with a
parameter p0 which acts as a smoothing value. The par-
ameter p0 is common to all projections, and guarantees
that they all play comparable roles prior to recombin-
ation. The final disease mapping function Γ(y) is defined
as Γ: R2→ R for any y in S as the average of the one-
dimensional projections γi(y) around y. When observed
equals expected, Γ is constant throughout the region and
we say that the map is flat.
To define an estimator for Γ, we assume F0 remains
known and suppose the locations of n cases are repre-
sented by random variables X1,…,Xn, independently iden-
tically distributed according to F. For each projection γi,
we consider the one-dimensional empirical cumulative
distribution function (ECDF) and use these to define con-
sistent estimators for γi(y) and Γ(y) for fixed y in S.
To adapt the framework above to discrete data, we re-
place the sample space R2 with the discrete collection of
centroids {z1,…,zm}. Discrete analogues of the one-
dimensional projections defined above are still valid and
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the typical desirable properties. For example some mild
conditions ensure that the same properties of consistent
and unbiased estimation guaranteed for the continuous
mapping function will remain in place as well for
discrete data. Application of the relative probability the-
ory is straightforward, and mathematical derivations and
necessary theorems are described elsewhere [17].
Simulations
To illustrate our approach to discrete data, we first apply
DBM to incident cases of leukaemia reported in the eight
counties of the upper part of New York State between
1978-1982 [25,26]. We then evaluate DBM for discrete data
with simulations in the unit disk. Performance is measured
as the accuracy to locate an increased risk of disease when
the underlying distribution is uniform. Data are first sam-
pled from a continuous distribution, then discretized at
four different levels. We study how accuracy changes across
five datasets. All analysis was done using the software R
[30], and the code is available upon request.
Data and simulated outbreaks
We consider the uniform distribution on the unit disk as
our continuous reference population, with CDF F0 and
PDF f0. The unit disk is defined as the two-dimensional
surface delimited by a circle of radius 1 centered at the
origin. Following our earlier work [7], cases are distrib-
uted as a mixture of the reference population and local-
ized increases in the number of cases (i.e. clusters). We
write the PDF f(x) for cases from a single cluster in sub-
region C of the study region as:
f xð Þ ¼ 0:9  f 0 xð Þ þ 0:1  g0 xð Þ
where g0 is the uniform distribution on C. We choose C
to be square-shaped, centered at a focus point randomly
selected from the region S. We fix the geographical ex-
tent, which we index by the side length of the square.
We denote this index by ‘diameter’, and consider four
values: 0.05, 0.2, 0.35, 0.5. The diameter and mixture of
each distribution (here 90%-10%) govern the risk in-
crease in C. For example if the diameter is 0.5, the prob-
ability of arising in C is 2.16 times higher under f
compared to f0. For each index value, we simulate 1000
datasets of size 100, within which the focus point is the
only parameter that varies. The left panel of Figure 1 il-
lustrates one such simulated dataset: 90 cases are drawn
uniformly in the unit disk, and 10 are sampled from a
small square in the region to represent a cluster.
Aggregation scheme
Following previous work [7], we create discrete spatial
data by aggregating the point data generated with f. Onthe unit disk, we superimpose several regular rectangular
grids of varying spacing. For a given grid spacing, spatial
locations generated under f and f0 are reassigned to the
centroid of the corresponding grid square (Figure 1,
right panel). Each centroid is slightly off-center to avoid
too regular an aggregation and produce a wider range of
disease scores. We consider four levels of aggregation,
constructed by setting the maximum number of adjacent
grid squares to 15, 10, 6, and 4. We index the level of ag-
gregation using the side length of a grid square, with
corresponding values 0.13, 0.2, 0.33, and 0.5. Table 1
gives the total number of grid squares where data drawn
from f can appear.
Implementation and evaluation of the mapping
We implement DBM for each side length from Table 1,
with N = 20 circle points and smoothing parameter p0 =
0.1. We represent the unit disk with r = 7827 grid points
on the unit disk, and calculate Γ at each point.
To evaluate DBM, we use the metric proposed in Jeffery
et al. [17,18]. The mixture f dichotomizes risk of disease
across the study region, and thus DBM performs well if it
locates the high and low risk grid points accurately. Given
a threshold γ, the disease score Γ(y) > γ when y is in the
cluster area and Γ(y) ≤ γ when y is outside the cluster area.
We define two complementary metrics of accuracy: sensi-
tivity, the proportion of grid points in the cluster area that
are given a high score, and specificity, the proportion of
grid points outside the cluster that are given a low score.
We then use a range of values for the threshold γ to con-
struct a Receiver Operating Characteristic (ROC) curve
and calculate the Area Under the Curve (AUC). The AUC
is our final measure of accurate location of the cluster
area, ranging from 0 (no cluster area is located) to 1 (the
cluster area is perfectly located).
We further investigate performance by exploring
where DBM locates a high risk area of ‘reasonable geo-
graphic extent’. For each iteration, we first identify the
subset of grid points of the study region with a high
DBM score (≥ 95th percentile of color palette). Iterations
are then classified as successful if: (a) this subset of grid
points does not differ from its corresponding convex
hull by more than eighty points (~ 1% of all grid points
in S); (b) the largest distance between any two points of
the corresponding convex hull is no more than 1.75
times the side length of a grid square. For each success-
ful iteration, we measure the distances from the center
of the located high risk area to the focus point of C and
to the ‘average centroid’, and take the difference between
these two distances (DiD). For example if the ten points
sampled in C are distributed among four adjacent grid
squares (4, 2, 2 and 4 points respectively), the average
centroid would be the average of the four centroids
weighted by 0.4, 0.2, 0.2, 0.4 respectively.
Figure 1 LEFT: Ninety points (grey) distributed according to a uniform in the unit disk, and 10 additional `outbreak' points (black)
from the square left of center. RIGHT: One level of aggregation for the unit disk, where the exact locations are reassigned to a single point in
the corresponding grid square. Each centroid location is represented by a ‘+’.
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Application to upstate New York leukaemia data
The upstate New York leukaemia data consists of 592
cases found across 790 discrete census block groups.
These data are available from StatLib (http://lib.stat.cmu.
edu/datasets/csb/) [31]. Each area is represented by the
coordinates of its centroid, and the number at risk is given
by the 1980 US Census. For 10% of the cases, address was
known only within two or three neighboring areas, and
thus their contribution was dispersed throughout the
concerned areas, weighted according to the census data,
which explains some of the non-integer counts [25].
The left panel of Figure 2 shows how centroid locations
follow similar variation in population density across the
study region. For our application, 592 case locations are
used to estimate f, while f0 is represented by the census
data. The 790 cells correspond to subregions Si, i = 1,…,
m = 790. We choose N = 40 circle points and smoothing
parameter p0 = 0.1. We superimpose a grid of r = 7038
grid points on the study region, and calculate Γ at each
grid point. We then use a color scale to map our esti-
mate, shown in the right panel of Figure 2. The color
scale is determined by resampling from the reference
population F0 [17,18]. Low values of Γ are in dark blue,
moving to green, orange, and then red as the values in-
crease. The resulting mapping shows higher risk in the
dense part of Broome county and possibly Cortland
county.Table 1 Number of grid squares per aggregation level,
where side length zero corresponds to continuous data
Side length 0 0.13 0.2 0.33 0.5
m ∞ 199 88 36 16Simulation results
We first illustrate mapping for a single simulation
using both point data and four levels of aggregation. In
Figure 3, we apply DBM to one iteration of our simula-
tions, where the cluster region C is defined by the dark
square in the left region of the disk (the diameter is set
to 0.2). Each of the five panels displays the mapping of
these data for one side length value from Table 1, and
the value of the AUC is displayed below. Each mapping
highlights a region in red, and as the side length increases
there is less overlap with C while the AUC decreases. In
addition, the center of the region highlighted in red is
close to the centroid of the grid square that contains the
largest portion of cluster area.
Results from 1000 iterations are presented in the four
panels of Figure 4. These show the distribution of the
1000 AUCs (y-axis) versus the side length of a grid square
(x-axis), for each of the four diameters. A side length equal
to zero means the locations are not aggregated (i.e. exact
point locations). Each blue dot corresponds to the mean
of the 1000 AUCs for one aggregation level. For each
diameter, the distribution of AUC remains the same for
the lower three side length values. Afterwards, there is a
drop in the mean and median, while the interquartile
range (IQR) widens much more. For the largest side
length, the performance of the mapping appears to be
the same regardless of the size of the diameter. Finally,
the loss in performance with increasing side length is
greater for smaller diameters.
Figure 5 displays the distribution of DiD against the
side length of a grid square when the cluster diameter is
0.2. The median DiD values are displayed as a colored
dot for each cluster diameters 0.05, 0.20, 0.35, and 0.50.
Our results show that at least 50% of the iterations loca-
ting a high risk area of ‘reasonable geographic extent’
Figure 2 LEFT: Location of the 790 centroids in upstate New York. Dotted lines mark county borderlines. RIGHT: Application of DBM
(N = 40, p0 = 0.1) to the 592 leukaemia cases.
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focus point.
Discussion
We adapt DBM to a discrete setting, where a centroid
point for each aggregation unit represents the location
of a case. This allows us to maintain the same approach
when mapping either continuous or discrete spatial
data. This common framework can lead to study the
application of DBM to several datasets simultaneously,Figure 3 DBM applied to continuous (Side length = 0) and discrete da
centered in the dark square (diameter = 0.2) and 90 points uniformly
AUC values.when spatial data are available at various levels of reso-
lution [6,32].
We have presented an application of DBM to leukaemia
data. Other analyses of this dataset have identified similar
hot spots, and raised possible connections with surroun-
ding toxic waste sites [33-35]. We believe that DBM adds
a valuable visualization tool to this collection of analyses.
We measure performance of mapping as the correct
localization of a cluster placed in the unit disk, using
similar metrics to Jones et al. [8]. Simulations show thatta (Side length = 0.13, 0.20, 0.33, 0.50) applied with 10 points
distributed in the unit disk (N = 20, p0 = 0.1), and corresponding
Figure 4 For each cluster diameter, boxplot of 1000 AUCs (y-axis) to locate high risk area for several aggregation levels (x-axis, side
length = 0 for exact location), from 1000 simulations. Means are represented as blue dots.
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data coarsens, although the decrease in AUC is less dra-
matic when the high risk area is large. Similar to other
studies [7,8,13,36], these results show that the strength
of any local change in the spatial distribution of casesFigure 5 Distribution of the Difference in Distance (DiD) from
the center of the located high risk area to the focus point of
the cluster and to the average centroid. The number e is the
number of iterations where DBM locates a high risk area of
reasonable geographic extent. For cluster diameter 0.2, the
distribution is displayed as a boxplot of the e DiD values. For each
cluster diameter 0.05, 0.20, 0.35 and 0.50, we report the median of
the e DiD values with a colored dot.will be identified differently depending on the level of
discreteness at which the spatial data are available.
The adaptation of DBM to discrete data relies on a
choice of centroids and our simulations show that the
quality of the mapping is dependent on their location.
Our results from Figure 5 suggest that hot spot clus-
ters can be well located when the average centroid is
close to the cluster focus point. This occurs when the
side length of the grid square is smaller or equal to
the cluster diameter, or when the cluster spreads
across several aggregated regions [7,8,23]. Waller
et al. have also shown that changing the location of
the centroid within each aggregation unit can affect
the inference (see [23], chapter 4). To accommodate
this drawback, some have suggested methods that are
centroid-free [37-39] including one mapping method
where the estimator of the intensity is based on a
least square approach weighted by the distribution of
the aggregated counts [40]. The effect of centroid
choice can be easily studied, and our method could
be expanded to be independent of centroid location
and instead depend on the support of the aggregation
unit by assigning the location of a case randomly in
the unit. The random process making such an assign-
ment might be uniform or based on other available
data, e.g. topological features. Regardless, the location
of case is then represented as continuous and our
original DBM method can be implemented. Further
study needs to assess how this approach would affect
the resulting mapping.
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in the unit disk and a dichotomized risk. Real data will
undoubtedly exhibit complexities of shape and intensity
of risk. Yet our simulations allow us to understand the
methodology in a simple setting, and focus on the im-
pact of a small number of already important parameters.
Concerns about privacy related to electronically col-
lected spatial data are prominently part of the public
discourse, which warrants careful and systematic metho-
dological study of the compromises imposed by coarsened
data.
Conclusion
Aggregation of spatial data typically destroys information
and thus impedes efforts to monitor these data for spatial
disturbances. We have shown that DBM can be imple-
mented for continuous and discrete spatial data. The ap-
plication to upstate NY data offers new possibilities for its
use and visualization of aggregated spatial data. However,
the resulting mapping can lose accuracy in the discrete
setting and our simulations suggest a complex influence
by the interaction between cluster diameter and level of
aggregation. The choice of centroids also has an impact
on the mapping output. The effect of spatial aggregation
on cluster detection, disease mapping, and other useful
methods in spatial epidemiology is complex and deserves
further study.
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